This inventor holds 3 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2001-2006.
Location History:
- Norwich, CT (US) (2001 - 2006)
- Gilford, CT (US) (2006)
Company Filing History:
Years Active: 2001-2006
Title: Juan C Colberg: Innovator in Pharmaceutical Chemistry
Introduction
Juan C Colberg is a notable inventor based in Gilford, CT (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 3 patents, showcasing his innovative approach to drug development and synthesis.
Latest Patents
Colberg's latest patents include significant advancements in the preparation of cephalosporins. One of his key inventions is a coupling process and intermediates useful for preparing cephalosporins. This process involves the preparation of 3-cyclic-ether-substituted cephalosporins, utilizing specific carboxylic acids or carboxylate salts in the presence of a solvent and a base. Another notable patent focuses on the resolution of 3-amino alkylnitriles, which relates to chiral N-acetyl-alpha-amino acid salts of optically active β-amino alkylnitriles. This invention provides a method for preparing optically active β-amino alkylnitriles by resolving racemic β-amino alkylnitriles using chiral N-acetyl-alpha-amino acids as a resolving agent.
Career Highlights
Colberg is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to various innovative projects aimed at improving healthcare outcomes through advanced drug formulations.
Collaborations
Throughout his career, Colberg has collaborated with esteemed colleagues, including Maurizio Zenoni and Giovanni Fogliato. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Juan C Colberg's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of essential medications, showcasing the importance of innovation in healthcare.